Cargando…
Editorial Commentary: Immunodeficiency at Start of Antiretroviral Therapy: The Persistent Problem of Late Presentation to Care
Autores principales: | Ford, Nathan, Mills, Edward J., Egger, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357289/ https://www.ncbi.nlm.nih.gov/pubmed/25516184 http://dx.doi.org/10.1093/cid/ciu1138 |
Ejemplares similares
-
Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts
por: Ford, Nathan, et al.
Publicado: (2015) -
Editorial Commentary: The Irreversibility of HIV Drug Resistance
por: Kouyos, Roger D., et al.
Publicado: (2015) -
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study
por: May, Margaret T., et al.
Publicado: (2016) -
Differing spectrum of HIV-associated ophthalmic disease among patients starting antiretroviral therapy in India and South Africa
por: Pathai, Sophia, et al.
Publicado: (2011) -
Association Between Belief in Medicine and Adherence to Antiretroviral Therapy Among Human Immunodeficiency Virus Adults in Zaira, Kaduna State, Nigeria
por: Eze, Rosemary A, et al.
Publicado: (2023)